GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.
about
Cytomegalovirus infection in transplant recipientsCMV: Prevention, Diagnosis and TherapyClinical immune-monitoring strategies for predicting infection risk in solid organ transplantationProspective, comprehensive, and effective viral monitoring in Cuban children undergoing solid organ transplantation.The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.Multicenter comparison of laboratory performance in cytomegalovirus and Epstein-Barr virus viral load testing using international standards.Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients.Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.Opportunistic infections complicating solid organ transplantation with alemtuzumab induction.Herpesviruses excretion in saliva of pediatric transplant recipients.Clinical significance of the single nucleotide polymorphism TLR2 R753Q in heart transplant recipients at risk for cytomegalovirus disease.Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study.Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation.Effect of mammalian target of rapamycin inhibitors on cytomegalovirus infection in kidney transplant recipients receiving polyclonal antilymphocyte globulins: a propensity score-matching analysis.Monitoring of intracellular adenosine triphosphate in CD4(+) T cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients.Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses.In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice.Association between individual and combined SNPs in genes related to innate immunity and incidence of CMV infection in seropositive kidney transplant recipients.Impact of antibiotic resistance on the development of recurrent and relapsing symptomatic urinary tract infection in kidney recipients.Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates.Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study.Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort.Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation.Does the calcineurin inhibitor have influence on cytomegalovirus infection in heart transplantation?Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients.Pretransplant interferon-γ secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation.Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients.
P2860
Q26801802-34CE194A-7B2E-47F5-A552-83DA1A2D6F02Q26824869-446A4360-B259-4CDD-90AD-E5529AF8EB9FQ26998832-8D9256D6-7473-43F1-A933-03B904E5935AQ33671565-BAE99511-8909-46BB-8630-22672C232075Q35106937-297A49F7-929B-4D04-98F9-8B7D5D591A4AQ35785478-CDA8B510-06D9-41EB-9D1D-22B945AEAD2DQ36730035-ADB1D6DB-D940-43C3-9758-B6974C75612BQ37973516-54C4A1FB-E03B-4B43-A812-7C42F30F2404Q38558078-BEF1D312-AB5F-4C63-9B54-02CFF829960FQ38638144-B2978EC9-2427-4C45-9F99-665913B93142Q39437974-8E755BDC-95A9-45BE-AF01-C46A96874C21Q40293836-E182D58D-889F-4C5C-9588-4FF2B59607DDQ40358580-F6C2EB8A-01E3-40FF-8353-1A34EB76E3FDQ40483831-7CAB3880-B69A-4A63-97E8-943FE9BF24CCQ40630330-2270D1FB-0B37-4126-8151-61F50C978C7DQ41128262-600B63AC-F271-4B33-A2BC-5942AE85FF8CQ41218897-FAE263C1-806E-49EC-8296-BFDE526842FEQ41233197-39F91440-A96E-4A95-B270-4565EB23C286Q41342348-57982C29-6747-44F0-B6D7-22F0A06C66DFQ41427501-3C853C58-B737-4CF2-A7A8-1EE3888E4B89Q41486566-871D2C43-F3FC-4572-860C-597947BBFCC7Q41506026-B934AE6F-D0CE-46DC-B056-00DC66C5C231Q41994978-3AF2E565-2815-47C1-A41C-F5A4A02678BCQ42208965-EEC073BB-8D9C-497A-99C6-151D6D3D668AQ42216221-2C3F480C-6C2B-47E4-92F2-B632133A1476Q42223053-E69D889B-5D67-43BD-B589-EE7BA70E0CAFQ42249961-84BDC873-E306-4D38-A489-5CB6BEDCF4D6Q44100013-486A9218-2FAF-42F8-A2BA-E2A72C463983Q45391655-04A6954A-8A38-4922-8EA4-DF2C2D738C2EQ54237859-E73FEB97-891C-49B7-BA7D-AAABBC808CBE
P2860
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
GESITRA-SEIMC/REIPI recommenda ...... lid-organ transplant patients.
@en
GESITRA-SEIMC/REIPI recommenda ...... lid-organ transplant patients.
@nl
type
label
GESITRA-SEIMC/REIPI recommenda ...... lid-organ transplant patients.
@en
GESITRA-SEIMC/REIPI recommenda ...... lid-organ transplant patients.
@nl
prefLabel
GESITRA-SEIMC/REIPI recommenda ...... lid-organ transplant patients.
@en
GESITRA-SEIMC/REIPI recommenda ...... lid-organ transplant patients.
@nl
P2093
P50
P1476
GESITRA-SEIMC/REIPI recommenda ...... olid-organ transplant patients
@en
P2093
Albert Pahissa
Alberto Rodriguez-Bernot
Asunción Moreno
David Navarro
Esteban Frauca
Evaristo Varo
Felipe Zurbano
Francisco Santos
GESITRA-SEIMC/REIPI
Jesús Fortún
P304
P356
10.1016/J.EIMC.2011.05.022
P50
P577
2011-09-17T00:00:00Z